IFCPC Paris 2026 World Congress takes place from 4 to 6 June 2026 at the Palais des Congrès de Versailles, with pre-congress workshops on 3 June. It is the first IFCPC World Congress held in France and brings together nearly 50 national societies working on prevention, screening and management of HPV-induced lesions. The audience is healthcare professionals involved in cervical cancer prevention, colposcopy and lower genital tract pathology.

The congress covers primary prevention, vaccination coverage, new vaccine protocols, screening, virology, molecular genetics, biomarkers, diagnosis and treatment, artificial intelligence, tailored care for high-risk populations, pregnancy and post-treatment follow-up, vaginal microbiota, CIN2 management, multifocal lesions and anal lesion screening. Abstract submission opened on 1 May 2025 and the page lists a submission deadline of 1 February 2026 in its detailed instructions, with notification in March 2026. Accepted abstracts are presented either as 5-minute oral presentations with questions or as electronic posters with a maximum five-slide presentation and oral commentary. The online programme links to an abstract book PDF. Registration fees are published in euros, so the GBP cost columns were left blank: late international registration is EUR750, late low/middle-income registration EUR580, late French registration EUR550, SFCPCV member EUR400, postgraduate student EUR150 and undergraduate student EUR35. Each registration includes congress sessions, sponsored sessions, exhibition and coffee breaks.